Navigates AgChem Downturn, Eyes FY27 Growth Driven by Pharma & New Products
PI Industries Limited · PIIND · NSE ·
• FY26 Consolidated Revenue stood at ₹67,137M with a 25% EBITDA margin and a strong net cash balance of ₹34 Bn. • The core AgChem business saw a decline due to a global industry downcycle, partially offset by a strong product mix. • PI Health Sciences (Pharma) was a key growth dr…